title: 17-beta-estradiol induces an inhibitor of active caspases.
abstract: We have shown previously that caspase-6 activity is lethal to human neurons (LeBlanc et al., 1999; Zhang et al., 2000). Here we find that 17-beta-estradiol but not 17-alpha-estradiol prevents caspase-6-mediated neuronal cell death. 17-beta-estradiol-treated neuronal extracts directly inhibit recombinant active caspase-6, caspase-3, caspase-7, and caspase-8 in vitro. We conclude that 17-beta-estradiol induces a caspase inhibitory factor (CIF) that is preventing neuronal apoptosis. The induction of CIF occurs within 10 min of 17-beta-estradiol exposure to neurons, does not require de novo protein synthesis, and involves mitogen-activated protein kinase activation. The effect is antagonized by the estrogen receptor antagonist tamoxifen. In contrast, 17-beta-estradiol does not induce CIF or prevent caspase-mediated cell death in cultured astrocytes. CIF does not act through oxidation of the caspase active site. CIF activity copurifies with proteins of between 12 and 14 kDa in size. Our results indicate that 17-beta-estradiol induces an inhibitor of active caspases through a receptor-mediated nongenomic pathway and provide an additional mechanism for the neuroprotective action of 17-beta-estradiol that is likely highly relevant to the understanding of the role of estrogen against Alzheimer's disease.
authors.affiliation: Departments of Neurology and Neurosurgery and Pediatrics, McGill University, Montréal, Québec, Canada H3A 2T5.
authors.forename: Y
authors.initials: Y
authors.lastname: Zhang
authors.forename: O
authors.initials: O
authors.lastname: Tounekti
authors.forename: B
authors.initials: B
authors.lastname: Akerman
authors.forename: C G
authors.initials: CG
authors.lastname: Goodyer
authors.forename: A
authors.initials: A
authors.lastname: LeBlanc
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D001253:Astrocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D053178:Caspase 6; D061945:Caspase Inhibitors; D020169:Caspases / Q000008:administration & dosage / Q000378:metabolism; D002478:Cells, Cultured; D004789:Enzyme Activation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D004958:Estradiol / Q000008:administration & dosage*; D006801:Humans; D008845:Microinjections; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D008970:Molecular Weight; D009474:Neurons / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D013237:Stereoisomerism
chemical_list: D061945:Caspase Inhibitors; D004791:Enzyme Inhibitors; D011500:Protein Synthesis Inhibitors; D004958:Estradiol; D020928:Mitogen-Activated Protein Kinases; C505514:CASP6 protein, human; D053178:Caspase 6; D020169:Caspases